Northern Trust Corp Acumen Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 308,850 shares of ABOS stock, worth $549,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,850

Previous 70,088 340.66%

Holding current value

$549,753

Previous $169,000 352.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.22 - $3.54 $530,051 - $845,217	238,762 Added 340.66%	308,850 $765,000
Q2 2024 Aug 14, 2024	BUY	$2.14 - $4.01 $28,494 - $53,393	13,315 Added 23.45%	70,088 $169,000
Q1 2024 May 14, 2024	BUY	$2.97 - $4.64 $282 - $440	95 Added 0.17%	56,773 $229,000
Q4 2023 Feb 13, 2024	BUY	$1.86 - $4.48 $907 - $2,186	488 Added 0.87%	56,678 $217,000
Q3 2023 Nov 13, 2023	BUY	$4.15 - $9.72 $99,998 - $234,213	24,096 Added 75.08%	56,190 $233,000
Q2 2023 Aug 11, 2023	SELL	$3.59 - $6.59 $229 - $421	-64 Reduced 0.2%	32,094 $154,000
Q1 2023 May 15, 2023	SELL	$3.75 - $6.65 $8,347 - $14,802	-2,226 Reduced 6.47%	32,158 $130,000
Q4 2022 Feb 13, 2023	BUY	$4.81 - $10.17 $41,568 - $87,889	8,642 Added 33.57%	34,384 $185,000
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $18,630 - $43,974	4,196 Added 19.47%	25,742 $259,000
Q2 2022 Aug 12, 2022	SELL	$3.08 - $4.88 $599,435 - $949,755	-194,622 Reduced 90.03%	21,546 $101,000
Q1 2022 May 13, 2022	BUY	$3.91 - $6.73 $473,829 - $815,568	121,184 Added 127.58%	216,168 $845,000
Q4 2021 Feb 08, 2022	BUY	$6.54 - $15.31 $49,592 - $116,095	7,583 Added 8.68%	94,984 $642,000
Q3 2021 Nov 15, 2021	BUY	$14.5 - $20.28 $1.27 Million - $1.77 Million	87,401 New	87,401 $1.3 Million

Others Institutions Holding ABOS

# of Institutions

Shares Held

41.8M

Call Options Held

57.7K

Put Options Held

749K

View Full List

About Acumen Pharmaceuticals, Inc.

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.1M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

More about ABOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Acumen Pharmaceuticals, Inc. Transaction History